13F Pro

SEC Form 4 reporting owner

Gheuens Sarah

Gheuens Sarah has filed 16 Form 4 transactions reported between December 30, 2025 and August 4, 2026, as Chief Medical Officer of AGIOS PHARMACEUTICALS, INC. and a reporting owner of Viridian Therapeutics, Inc.\DE.

Name as filed: Gheuens Sarah

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$1.3M
6 lines
Companies
2
with Form 4 filings
Latest transaction
Aug 4, 2026
transaction date

Roles and reported holdings

  • AGIOAGIOS PHARMACEUTICALS, INC.
    Dec 30, 2025 – Aug 4, 2026

    Chief Medical Officer

    Held directly54,645 sh as of Aug 4, 2026 · Form 4

    24 months: $1.3M sold

  • VRDNViridian Therapeutics, Inc.\DE
    Jul 1, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 16 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 4, 2026AGIOChief Medical OfficerOpen-market saleCode S · direct30,000$914K@ $30.48Form 4
Jul 1, 2026VRDNGrant or awardCode A · direct32,341—Form 4
Jul 1, 2026AGIOChief Medical OfficerOpen-market saleCode S · direct4,007$151K@ $37.56Form 4
Jul 1, 2026AGIOChief Medical OfficerOption exerciseCode M · direct8,375—Form 4
Jun 18, 2026AGIOChief Medical OfficerOption exerciseCode M · direct3,000—Form 4
Apr 2, 2026AGIOChief Medical OfficerOpen-market saleCode S · direct2,940$102K@ $34.71Form 4
Apr 2, 2026AGIOChief Medical OfficerOption exerciseCode M · direct8,500—Form 4
Mar 2, 2026AGIOChief Medical OfficerOpen-market saleCode S · directAlso reported by Burns James William, Jones Cecilia, Milanova Tsveta1,681$49K@ $28.96Form 4
Mar 2, 2026AGIOChief Medical OfficerOption exerciseCode M · direct5,666—Form 4
Mar 2, 2026AGIOChief Medical OfficerOpen-market saleCode S · directAlso reported by Burns James William, Jones Cecilia, Milanova Tsveta1,187$34K@ $28.96Form 4
Mar 2, 2026AGIOChief Medical OfficerOption exerciseCode M · direct4,000—Form 4
Mar 1, 2026AGIOChief Medical OfficerGrant or awardCode A · direct52,000—Form 4
Mar 1, 2026AGIOChief Medical OfficerGrant or awardCode A · direct22,000—Form 4
Mar 1, 2026AGIOChief Medical OfficerGrant or awardCode A · direct14,000—Form 4
Dec 30, 2025AGIOChief Medical OfficerOpen-market saleCode S · directAlso reported by Burns James William, Milanova Tsveta, Jones Cecilia2,932$79K@ $27.09Form 4
Dec 30, 2025AGIOChief Medical OfficerOption exerciseCode M · direct6,000—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.